Rchr
J-GLOBAL ID：201301097814498705
Update date: Sep. 30, 2022
Tachihara Motoko
タチハラ モトコ | Tachihara Motoko
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Kobe University Graduate School of Medicine Faculty of Medical Sciences
About Kobe University Graduate School of Medicine Faculty of Medical Sciences
Search "Kobe University Graduate School of Medicine Faculty of Medical Sciences"
Detailed information
Job title：
Associate Professor
Research theme for competitive and other funds (3)：
2017 - 2020 肺腺がんの微小乳頭状構造のオルガノイド培養システムの確立
2013 - 2016 アムルビシンによる薬剤耐性化機構の解析
2016 - (AMED)高齢者進行非扁平上皮非小細胞肺癌に対する標準的化学療法の確立に関する研究/JCOG1210/WJOG7813L『高齢者進行非扁平上皮非小細胞肺癌に対するドセタキセル単剤療I
Papers (46)：
Naoko Chayahara, Toru Mukohara, Motoko Tachihara, Yoshimi Fujishima, Atsushi Fukunaga, Ken Washio, Masatsugu Yamamoto, Kyosuke Nakata, Kazuyuki Kobayashi, Kei Takenaka, et al. Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE). The oncologist. 2019. 24. 7. 885-e413
Kiyoko Koyama, Naoko Katsurada, Naoe Jimbo, Motoko Tachihara, Daisuke Tamura, Kyosuke Nakata, Tatsuya Nagano, Masatsugu Yamamoto, Hiroshi Kamiryo, Kazuyuki Kobayashi, et al. Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma. Pathology international. 2019. 69. 5. 294-299
Katsurada M, Nagano Tatsuya, Tachihara Motoko, Kiriu T, Furukawa K, Koyama K, Otoshi T, Sekiya R, Hazama D, Tamura D, et al. Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer. Anticancer Res. 2019. 39. 2. 815-825
堂國良太, Tachihara Motoko, 田村大介, 中田恭介, 堀朱矢, 山本正嗣, 上領博, 小林和幸, 西村善博. 局所麻酔下胸腔鏡下生検で診断した肺癌肉腫の芽腫様亜型の1例. 気管支学. 2019. 41. 1. 40-45
Katsurada Naoko, Tachihara Motoko, Jimbo Naoe, Koyama K, Nakata K, Nagano Tatsuya, Yamamoto Masatsugu, Otera Hiroshi, Kobayashi Kazuyuki, Nishimura Yoshihiro. Successful Treatment of ROS1-rearranged Lung Cancer Complicated by Hypertrophic Pulmonary Osteoarthropathy with Crizotinib Therapy: A Case Report. Intern Med. 2019
ｍore...
MISC (2)：
Nagano Tatsuya, Tachihara Motoko, Nishimura Yoshihiro. Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Curr Cancer Drug Targets. 2018. 19. 8. 595-630
Nagano Tatsuya, Tachihara Motoko, Nishimura Yoshihiro. Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy. Cells. 2018. 7. 11
Lectures and oral presentations (71)：
免疫チェックポイント阻害薬で治療したPD-L1陽性肺癌に対する好中球リンパ球比の検討
(第58回 日本肺癌学会学術集会 2018)
免疫チェックポイント阻害剤投与例における赤血球容積粒度分布幅の有用性
(第59回 日本肺癌学会学術集会 2018)
無症候性脳転移を有する非小細胞肺癌に対するシスプラチン+ペメトレキセド+ベバシズマブの第II相試験
(第60回 日本肺癌学会学術集会 2018)
間質性陰影合併肺癌における抗PD-1抗体による間質性陰影増悪のリスク因子の検討
(第61回 日本肺癌学会学術集会 2018)
Gemcitabine enhances anti-tumor activity of Paclitaxel by Modulating Tubulin Acetylation
(Asian Pacific Society of Respirology 2018 2018)
ｍore...
Education (1)：
- 2000 Fukushima Medical University School of Medicine School of Medicine
Professional career (1)：
博士(医学) (福島県立医科大学)
Awards (1)：
2016 - 西日本がん研究機構(WJOG) 平成27年度有吉・福岡賞 個人・臨床研究
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
